Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-25-003821
Filing Date
2025-05-15
Accepted
2025-05-15 16:30:39
Documents
77
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bglc_10q.htm   iXBRL 10-Q 1170257
2 CERTIFICATION bglc_ex311.htm EX-31.1 10822
3 CERTIFICATION bglc_ex321.htm EX-32.1 3489
  Complete submission text file 0001477932-25-003821.txt   6072363

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bglc-20250331.xsd EX-101.SCH 56973
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bglc-20250331_lab.xml EX-101.LAB 288715
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bglc-20250331_cal.xml EX-101.CAL 57489
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bglc-20250331_pre.xml EX-101.PRE 250479
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bglc-20250331_def.xml EX-101.DEF 122716
80 EXTRACTED XBRL INSTANCE DOCUMENT bglc_10q_htm.xml XML 1216024
Mailing Address 10-2 TOWER B, VERTICAL BUSINESS SUITE, 8 JALAN KERINCHI, KUALA LUMPUR N8 59200
Business Address 10-2 TOWER B, VERTICAL BUSINESS SUITE, 8 JALAN KERINCHI, KUALA LUMPUR N8 59200 1-307-241-6898
BioNexus Gene Lab Corp (Filer) CIK: 0001737523 (see all company filings)

EIN.: 262124961 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41750 | Film No.: 25954120
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)